Cancer Prevention and Screening Blog - Items
/filters:format(webp)/prod01/channel_330/wiph/media/the-wolfson-institute-of-population-health-wiph/images/Oleg-Blyuss.jpg)
Five Minutes With... Dr Oleg Blyuss
Dr Oleg Blyuss is a Reader in Data Science and Statistics at the Centre for Cancer Screening, Prevention and Early Diagnosis. His research is around development of predictive models that use multi-omic data for the early detection of cancer. Current grants aim at the analysis of longitudinal data arising from serum biomarkers and MRI images, which allows for a personalised approach in early detection. Oleg holds a PhD in Applied Mathematics from Oles Honchar Dnipro National University, Ukraine.
Date added: Thursday, April 3, 2025
Mel Ramasawmy- Co-designing videos to explain ‘large language models’ in healthcare and research
Large language models (LLMs) are a type of artificial intelligence which are being used more often in health care and research. Working with a group of PPIE contributors in Tower Hamlets, our research team co-created accessible resources to support the public to engage in LLM research and use them more safely.
Date added: Tuesday, November 4, 2025
/filters:format(webp)/prod01/channel_330/wiph/media/the-wolfson-institute-of-population-health-wiph/loubna-speech-picture-1-(1).png)
Loubna Bijdiguen’s inspiring speech, “My Journey with PPI at QMUL: A Personal Reflection.”
One of the highlights of our recent CCSPED Away Day was a powerful speech from PPI representative Loubna Bijdiguen. In this personal reflection, Loubna shares her journey into research involvement and why meaningful community engagement matters for early cancer detection research.
Date added: Tuesday, June 9, 2026
Zero Deaths Under 25: How HPV Vaccination Is Transforming Cervical Cancer Prevention
A generation ago, eliminating cervical cancer deaths seemed unimaginable. Today, HPV vaccination is making that vision a reality. Professor Peter Sasieni explains how one of the greatest public health successes of our time is saving lives.
Date added: Thursday, June 18, 2026
Seven paradoxes of prostate specific antigen (PSA) testing and what they mean for screening
What if a screening test could miss cancers, and that was actually a good thing? In this blog, Dr Adam Brentnall unpacks seven paradoxes of PSA testing and explores why a smarter, more targeted approach could improve prostate cancer screening and save more lives.
Date added: Thursday, July 9, 2026
TRANSFORM: a new era for prostate cancer screening
Why don’t we screen for prostate cancer? and could we be on the verge of changing that? Despite being the most common cancer in men in the UK, there is still no national screening programme. Previous approaches found too many cancers that would never have caused harm, leading to unnecessary tests and treatment. Now, advances in MRI and genetic risk assessment could change the future of prostate cancer screening. The TRANSFORM trial is exploring whether we can find the cancers that matter, save lives, and reduce unnecessary harm.
Date added: Friday, July 17, 2026
Rethinking prostate specific antigen (PSA) testing policy: why age matters
When it comes to PSA testing, more isn't always better. While testing can reduce deaths from prostate cancer, the benefits decrease and the harms increase as men get older. Dr Adam Brentnall explains why age matters, what the evidence shows, and why current NHS guidance should change.
Date added: Friday, July 24, 2026
Five Minutes With… Dr Matejka Rebolj
Meet the people behind the research. In our Five Minutes With… series, Dr Matejka Rebolj reflects on the unexpected journey that led her into cancer epidemiology, the future of cancer prevention, and why rigorous science and knowing when something is "good enough" matters more than ever.
Date added: Thursday, August 6, 2026
Five Minutes With... Dr Maribel Almonte
What does it take to turn the tools we have to prevent cervical cancer into real change for women around the world? In our latest Five Minutes With…, Dr Maribel Almonte reflects on what inspired her career, the challenges still facing cervical cancer prevention globally, and the innovations giving her hope for the future.
Date added: Thursday, August 27, 2026
Five Minutes With... Dr Alison Berner
From cancer inequalities to co-producing research with patients and communities, Dr Alison Berner shares what inspired her career, the research she’s most excited about, and her hopes for the future of cancer prevention and care.
Date added: Tuesday, September 8, 2026
The cost of caution: rethinking how we make cancer screening decisions
Cancer screening is often presented as a straightforward question of evidence: does a screening test do more good than harm? But decisions about whether to introduce, change or withdraw a screening programme are rarely that simple.
Date added: Thursday, September 17, 2026